Shaikh M Yusuf, Mars J Simon, Heaven Chris J
Christopher Home Eye Unit, Royal Albert Edward Infirmary, Wigan, United Kingdom.
J Cataract Refract Surg. 2003 Dec;29(12):2372-7. doi: 10.1016/s0886-3350(03)00137-8.
To compare the effects on the pupil of pretreatment with prednisolone 1% eyedrops, flurbiprofen 0.03% eyedrops, and sodium chloride 0.9% eyedrops in patients having phacoemulsification cataract surgery.
Christopher Home Eye Unit, Royal Albert Edward Infirmary, Wigan, United Kingdom.
One hundred thirty-six white patients having phacoemulsification with no history of eye disease, antiinflammatory medication, or diabetes were enrolled in this prospective randomized double-blind study. Patients were allocated to receive flurbiprofen 0.03%, prednisolone 1%, or sodium chloride 0.9% (placebo) eyedrops at 30-minute intervals beginning 2 hours before surgery. All patients received cyclopentolate 1% and phenylephrine 2.5% drops preoperatively and epinephrine 1:10(6) intraoperatively in the intraocular irrigating solution. The pupil diameter was measured from a television screen at the preset magnification of the operating microscope immediately before the incision, at the end of nucleus emulsification, at the end of irrigation/aspiration (I/A), and at the end of surgery. One hundred twelve patients with a baseline pupil diameter of at least 6.0 mm who had uneventful phacoemulsification were analyzed.
The baseline pupil diameters were statistically similar. An analysis of variance did not reveal an overall significant mydriasis-maintaining effect of prednisolone or flurbiprofen compared to the placebo at any stage of surgery (P =.16 to.37). The 95% confidence interval showed flurbiprofen to be superior to prednisolone at the end of surgery. According to the paired t test, the reduction from the baseline at the end of I/A in the prednisolone group (P =.051) and at the end of surgery in the flurbiprofen group (P =.22) was not significant.
In the presence of epinephrine in the intraocular irrigating solution, both prednisolone 1% and flurbiprofen 0.03% failed to maintain mydriasis at the crucial steps of nuclear emulsification and cortical I/A.
比较1%泼尼松龙滴眼液、0.03%氟比洛芬滴眼液和0.9%氯化钠滴眼液(安慰剂)预处理对白内障超声乳化手术患者瞳孔的影响。
英国维冈皇家阿尔伯特爱德华医院克里斯托弗之家眼科。
136例无眼部疾病、抗炎药物使用史或糖尿病史且行超声乳化手术的白人患者纳入这项前瞻性随机双盲研究。患者在手术前2小时开始每隔30分钟接受0.03%氟比洛芬、1%泼尼松龙或0.9%氯化钠(安慰剂)滴眼液滴眼。所有患者术前均接受1%环喷托酯和2.5%去氧肾上腺素滴眼液滴眼,术中眼内冲洗液中加入1:10(6)肾上腺素。在切口前、核乳化结束时、冲洗/抽吸(I/A)结束时及手术结束时,于手术显微镜预设放大倍数下从电视屏幕测量瞳孔直径。对112例基线瞳孔直径至少6.0 mm且超声乳化手术过程顺利的患者进行分析。
基线瞳孔直径在统计学上相似。方差分析显示,与安慰剂相比,泼尼松龙或氟比洛芬在手术任何阶段均未显示出总体显著的散瞳维持效果(P = 0.16至0.37)。95%置信区间显示,手术结束时氟比洛芬优于泼尼松龙。根据配对t检验,泼尼松龙组I/A结束时(P = 0.051)及氟比洛芬组手术结束时(P = 0.22)较基线的缩小不显著。
眼内冲洗液中存在肾上腺素时,1%泼尼松龙和0.03%氟比洛芬在核乳化及皮质I/A的关键步骤均未能维持散瞳。